TipRanks
Go Ultimate55% OFF

KARY ELDRED Insider Profile

4 Followers

KARY ELDRED, Director at Galectin Therapeutics, holds 70.11K shares in Galectin Therapeutics (Ticker: GALT). Most recently, KARY ELDRED Bought 300 shares of Galectin Therapeutics on Feb 09, 2026 for an estimated value of $810.00.

KARY ELDRED's Trading History

GALT
Galectin Therapeutics
Feb 09, 2026DirectorInformative Buy810.00$232.76K
GALT
Insider Shares: 70.11K (0.11%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 09, 2026Informative Buy$810.00300$2.70+22.00%
Dec 23, 2025Informative Buy$2.61K700$3.73-16.70%
Jul 22, 2025Informative Buy$2.92K1,000$2.92+22.30%
Dec 26, 2024Informative Buy$11.04K13,469$0.82+365.50%
Oct 23, 2024Informative Buy$1.30K500$2.60+98.80%

You May Also Like

KARY ELDRED insider profile FAQ

What is the percentage of profitable transactions made by KARY ELDRED?
The percentage of profitable transactions made by KARY ELDRED is 67%.
What is the average return per transaction made by KARY ELDRED?
The average return per transaction made by KARY ELDRED is 43.40%.
What stocks does KARY ELDRED hold?
KARY ELDRED holds: GALT stocks.
What was KARY ELDRED’s latest transaction?
KARY ELDRED’s latest transaction was an Informative Buy of $810.00.
What was KARY ELDRED's most profitable transaction?
KARY ELDRED’s most profitable transaction was an Informative Buy of GALT stock on December 26, 2024. The return on the trade was 365.50%.
What is KARY ELDRED's role in Galectin Therapeutics?
KARY ELDRED's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.